Article
Significance of KIT exon 17 mutation depends on mutant level rather than positivity in core-binding factor acute myeloid leukemia.
Blood cancer journal - 15 Jan 2016
Jang W, Yoon J-H, Park J, Lee G D, Kim J, Kwon A, Choi H, Han K, Nahm C H, Kim H-J, Min W-S, Kim M, Kim Y
Abstract excerpt
KIT exon 17 mutation is a poor prognostic factor in core-binding factor acute myeloid leukemia. However, the mutation detection method used for risk assessment is not assigned. It is necessary to verify the analytical and clinical performance before applying new methods. Herein, we firstly applied a highly sensitive allele-specific, real-time quantitative PCR (AS-qPCR) assay to analyze KIT mutations, which...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
